1079396-24-9

Basic information

• Product Name: 4-(5-AMino-6-chloro-pyriMidin-4-ylaMino)-piperidine-1-carboxylic acid tert-butyl ester
• Synonyms: 4-(5-AMino-6-chloro-pyriMidin-4-ylaMino)-piperidine-1-carboxylic acid tert-butyl ester;tert-butyl 4-(5-amino-6-chloropyrimidin-4-ylamino)piperidine-1-carboxylate
• CAS NO: 1079396-24-9
• Molecular Formula: C14H22ClN5O2
• Molecular Weight: 327.80978
• Mol File: 1079396-24-9.mol

Chemical Properties

• Boiling Point: 487.3±45.0 °C(Predicted)
• Appearance: /
• Density: 1.309±0.06 g/cm3(Predicted)
• PKA: 2.60±0.10(Predicted)
• CAS DataBase Reference: 4-(5-AMino-6-chloro-pyriMidin-4-ylaMino)-piperidine-1-carboxylic acid tert-butyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(5-AMino-6-chloro-pyriMidin-4-ylaMino)-piperidine-1-carboxylic acid tert-butyl ester(1079396-24-9)
• EPA Substance Registry System: 4-(5-AMino-6-chloro-pyriMidin-4-ylaMino)-piperidine-1-carboxylic acid tert-butyl ester(1079396-24-9)

Safety Data

• Hazardous Substances Data: 1079396-24-9(Hazardous Substances Data)

Upstream product

• 5413-85-4 5-amino-4,6-dichloropyridimine 
• 87120-72-7 1-(tert-butoxycarbonyl)-4-aminopiperidine 
• 1079396-23-8 tert-butyl 4-(6-chloro-5-nitropyrimidin-4-ylamino)piperidine-1-carboxylate 

Relevant articles and documents

Imidazole derivative and application thereof as TRPV4 inhibitor

The invention relates to imidazole derivatives of formula (I) and pharmaceutically acceptable salts, isomers, prodrugs and pharmaceutical compositions thereof. The compounds are inhibitors of vanilloid 4 type transient receptor potential channels (TRPV4).

BICYCLIC HETEROCYCLE DERIVATIVES AND THEIR USE AS GPCR MODULATORS

The present invention relates to Bicyclic Heterocycle Derivatives of Formula (I), compositions comprising a Bicyclic Heterocycle Derivative, and methods of using the Bicyclic Heterocycle Derivatives for treating or preventing obesity, diabetes, a diabetic

[6,5]-BICYCLIC GPR119 G PROTEIN-COUPLED RECEPTOR AGONISTS

Novel compounds are provided which are GPR119 G protein-coupled receptor modulators. GPR119 G protein-coupled receptor modulators are useful in treating, preventing, or slowing the progression of diseases requiring GPR119 G protein-coupled receptor modulator therapy. These novel compounds have the structure: or stereoisomers or prodrugs or pharmaceutically acceptable salts thereof, wherein n2, n3, n4, A, B, D, E, G, J, Y, R1 and R2 are defined herein.